Extended-Release Naltrexone and Harm Reduction Counseling for Chronically Homeless People With Alcohol Dependence

REFERENCES

• Fazel S, Khosla V, Doll H, Geddes J. The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis. PLoS Med. 2008;5:e225.
   PubMed Web of Science ®Google Scholar
• Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend. 2004;74:223–234.
   PubMed Web of Science ®Google Scholar
• Sullivan G, Burnam A, Koegel P. Pathways to homelessness among the mentally ill. Soc Psychiatry Psychiatr Epidemiol. 2000;35:444–450.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization; 2011.
   Google Scholar
• Eyrich-Garg KM, Cacciola JS, Carise D, Lynch KG, McLellan AT. Individual characteristics of the literally homeless, marginally housed and impoverished in a US substance abuse treatment-seeking sample. Soc Psychiatry Psychiatr Epidemiol. 2008;43:831–842.
   PubMed Web of Science ®Google Scholar
• Hwang SW. Homelessness and health. CMAJ. 2001;164:229–233.
   PubMed Web of Science ®Google Scholar
• Homeless Emergency and Rapid Transition to Housing (HEARTH) ActHomeless Emergency and Rapid Transition to Housing (HEARTH) Act, S. 896–38(2009).
   Google Scholar
• Martens WH. A review of physical and mental health in homeless persons. Public Health Rev. 2001;29:13–33.
   PubMedGoogle Scholar
• Hawke W, Davis M, Erlenbusch B. Dying Without Dignity: Homeless Deaths in Los Angeles County. Los Angeles, CA: Los Angeles Coalition to End Hunger & Homelessness; 2007.
   Google Scholar
• O’Connell JJ. Premature Mortality in Homeless Populations: A Review of the Literature. Nashville, TN: National Health Care for the Homeless Council; 2005.
   Google Scholar
• Hwang SW, Wilkins R, Tjepkema M, O’Campo P, Dunn JR. Mortality among residents of shelters, rooming houses and hotels in Canada: 11 year follow-up. BMJ. 2009;339:b4036.
   PubMed Web of Science ®Google Scholar
• Larimer ME, Malone DK, Garner MD, et al. Health care and public service use and costs before and after provision of housing for chronically homeless persons with severe alcohol problems. JAMA. 2009;301:1349–1357.
   PubMed Web of Science ®Google Scholar
• Rosenheck RA, Morrissey J, Lam J, et al. Service system integration, access to services, and housing outcomes in a program for homeless persons with severe mental illness. Am J Public Health. 1998;88:1610–1615.
   PubMed Web of Science ®Google Scholar
• Wenzel SL, Burnam MA, Koegel P, et al. Access to inpatient or residential substance abuse treatment among homeless adults with alcohol or other drug use disorders. Med Care. 2001;39:1158–1169.
   PubMed Web of Science ®Google Scholar
• Orwin RG, Garrison-Mogren R, Jacobs ML, Sonnefeld LJ. Retention of homeless clients in substance abuse treatment: findings from the National Institute on Alcohol Abuse and Alcoholism Cooperative Agreement Program. J Subst Abuse Treat. 1999;17:45–66.
   PubMed Web of Science ®Google Scholar
• Polcin DL. Criminal justice coercion in the treatment of alcohol problems: an examination of two client subgroups. J Psychoactive Drugs. 1999;31:137–143.
   PubMed Web of Science ®Google Scholar
• Collins SE, Clifasefi SL, Dana EA, et al. Where harm reduction meets Housing First: exploring alcohol's role in a project-based Housing First setting. Int J Drug Policy. 2012;23:111–119.
   PubMed Web of Science ®Google Scholar
• Grazioli VS, Collins SE, Daeppen J-B, Larimer ME. Perceptions of alcoholics anonymous among chronically homeless individuals with alcohol-use disorders. Int J Drug Policy, 2014. doi: 10.1016/j.drugpo.2014.10.009
   Google Scholar
• Pettinati HM, Monterosso J, Lipkin C, Volpicelli JR. Patient attitudes toward treatment predict attendance in clinical pharmacotherapy trials of alcohol and drug treatment. Am J Addict. 2003;12:324–335.
   PubMed Web of Science ®Google Scholar
• Long CG, Williams M, Midgley M, Hollin CR. Within-program factors as predictors of drinking outcome following cognitive-behavioral treatment. Addict Behav. 2000;25:573–578.
   PubMed Web of Science ®Google Scholar
• Kertesz SG, Horton NJ, Friedmann PD, Saitz R, Samet JH. Slowing the revolving door: stabilization programs reduce homeless persons’ substance use after detoxification. J Subst Abuse Treat. 2003;24:197–207.
   PubMed Web of Science ®Google Scholar
• Richman A, Neumann B. Breaking the “detox-loop” for alcoholics with social detoxification. Drug Alcohol Depend. 1984;13:65–73.
   PubMed Web of Science ®Google Scholar
• Becker HC. Kindling in alcohol withdrawal. Alcohol Health Res World. 1998;22:25–33.
   PubMed Web of Science ®Google Scholar
• Podymow T, Turnbull J, Coyle D, Yetisir E, Wells G. Shelter-based managed alcohol administration to chronically homeless people addicted to alcohol. CMAJ. 2006;174:45–49.
   PubMed Web of Science ®Google Scholar
• Svoboda T. Measuring the ‘Reduction’ in a Harm Reduction Program for Homeless Men Experiencing Harms Related to Alcohol Abuse and Problem Behaviors. Dissertation. University of Toronto. Toronto: University of Toronto; 2006.
   Google Scholar
• Collins SE, Malone DK, Clifasefi SL, et al. Project-based Housing First for chronically homeless individuals with alcohol problems: within-subjects analyses of two-year alcohol-use trajectories. Am J Public Health. 2012;102:511–519.
   PubMed Web of Science ®Google Scholar
• Collins SE, Clifasefi SL, Logan DE, Samples L, Somers J, Marlatt GA. Harm reduction: current status, historical highlights and basic principles. In: Marlatt GA, Witkiewitz K, Larimer ME, eds. Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors. 2nd ed. New York: Guilford; 2011:3–35. http://www.guilford.com/excerpts/marlatt2.pdf. Accessed March 21, 2014.
   Google Scholar
• Tsemberis S. Housing First: The Pathways Model to End Homelessness for People With Mental Illness and Addiction. Center City, MN: Hazelden; 2010.
   Google Scholar
• Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet. 2010;376:551–563.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hichkman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376:285–301.
   PubMed Web of Science ®Google Scholar
• Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41:777–813.
   PubMed Web of Science ®Google Scholar
• Dimeff LA, Baer JS, Kivlahan DR, Marlatt GA. Brief Alcohol Screening and Intervention for College Students (BASICS): A Harm Reduction Approach. New York: Guilford Press; 1999.
   Google Scholar
• Neighbors C, Larimer ME, Lostutter TW, Wood BA. Harm reduction and individually-focused alcohol prevention. Int J Drug Policy. 2006;17:304–309.
   PubMed Web of Science ®Google Scholar
• Marlatt GA. Harm reduction: come as you are. Addict Behav. 1996;21:779–788.
   PubMed Web of Science ®Google Scholar
• Sobell MB, Sobell LC. Controlled drinking after 25 years: how important was the great debate? Addiction. 1995;90:1149–1153.
   PubMed Web of Science ®Google Scholar
• Miller WR, Rollnick S. When goals differ. In: Miller WR, Rollnick S, eds. Motivational Interviewing: Helping People Change. 3rd ed. New York: Guilford Press; 2012:121–130.
   Google Scholar
• National Institute on Alcohol Abuse and Alcoholism. Helping Patients Who Drink Too Much: A Clinician's Guide. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2005. NIH publication no. 05-3769.
   Google Scholar
• Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction. 1993;88:315–336.
   PubMed Web of Science ®Google Scholar
• Sobell MB, Sobell LC. Second year treatment outcome of alcoholics treated by individualized behavior therapy: results. Behav Res Ther. 1976;14:195–215.
   PubMed Web of Science ®Google Scholar
• McIntosh MC, Sanchez-Craig M. Moderate drinking: an alternative treatment goal for early-stage problem drinking. CMAJ. 1984;131:873–876.
   PubMed Web of Science ®Google Scholar
• Miller WR, Pechacek TF, Hamburg S. Group behavior therapy for problem drinkers. Int J Addict. 1981;16:829–839.
   PubMed Web of Science ®Google Scholar
• Miller WR, Wilbourne PL. Mesa grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002;97:265–277.
   PubMed Web of Science ®Google Scholar
• McQueen J, Howe TE, Allan L, Mains D, Hardy V. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev. 2011;(8):CD005191.
   Google Scholar
• Kaner EF, Dickinson HO, Beyer F, et al. The effectiveness of brief alcohol interventions in primary care settings: a systematic review. Drug Alcohol Rev. 2009;28:301–323.
   PubMed Web of Science ®Google Scholar
• Martin GW, Rehm J. The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the evidence. Can J Psychiatry. 2012;57:350–358.
   PubMed Web of Science ®Google Scholar
• Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009;70:516–527.
   PubMed Web of Science ®Google Scholar
• Ferri M, Amato L, Davoli M. Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database Syst Rev. 2006;(3):CD005032.
   PubMed Web of Science ®Google Scholar
• Garbutt JC. The state of pharmacotherapy for the treatment of alcohol dependence. J Subst Abuse Treat. 2009;36:S15–S23.
   PubMed Web of Science ®Google Scholar
• Denning P, Little J. Practicing Harm Reduction Psychotherapy: An Alternative Approach to Addictions. New York: Guilford Press; 2011.
   Google Scholar
• Tartarsky A. Harm Reduction Psychotherapy: A New Treatment for Drug and Alcohol Problems. Plymouth, UK: Rowman & Littlefield Publishers; 2002.
   Google Scholar
• Marlatt GA. Basic prinicples and strategies of harm reduction. In: Marlatt GA, ed. Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors. New York: Guilford Press; 1998:49–66.
   Google Scholar
• Heather N. Controlled drinking, harm reduction and their roles in the response to alcohol-related problems. Addict Res Theory. 2006;14:7–18.
   Web of Science ®Google Scholar
• Ray LA, Chin PF, Miotto K. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action and pharmacogenetics. CNS Neurol Disord Drug Targets. 2010;9:13–22.
   PubMed Web of Science ®Google Scholar
• Subbaraman MS, Lendle S, van der Laan M, Kaskutas LA, Ahern J. Cravings as a mediator and moderator of drinking outcomes in the COMBINE study. Addiction. 2013; 108:1737–1744.
   PubMed Web of Science ®Google Scholar
• O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry. 1992;49:881–887.
   PubMed Web of Science ®Google Scholar
• Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876–880.
   PubMed Web of Science ®Google Scholar
• O’Malley SS, Jaffe AJ, Chang G, et al. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry. 1996;53:217–224.
   PubMed Web of Science ®Google Scholar
• Rösner S, Leucht S, Lehert P, Soyka M. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. J Psychopharmacol. 2008;22:11–23.
   PubMed Web of Science ®Google Scholar
• Srisurapanont M, Jarusuraisin N. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2008;(2):CD001867.
   Google Scholar
• Pettinati HM, O’Brien CP, Rabinowitz AR, et al. The status of naltrexone in the treatment of alcohol dependence. J Clin Psychopharmacol. 2006;26:610–625.
   PubMed Web of Science ®Google Scholar
• Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;(12):CD001867.
   PubMed Web of Science ®Google Scholar
• Jarosz J, Miernik K, Wachal M, Walczak J, Krumpl G. Naltrexone (50 mg) plus psychotherapy in alcohol-dependent patients: a meta-analysis of randomized controlled trials. Am J Drug Alcohol Abuse. 2013;39:144–160.
   PubMed Web of Science ®Google Scholar
• Bouza C, Angeles M, Muñoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction. 2004;99:811–828.
   PubMed Web of Science ®Google Scholar
• Pettinati HM, Volpicelli JR, Pierce JD, O’Brien CP. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis. 2000;19:71–83.
   PubMed Web of Science ®Google Scholar
• Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O’Brien CP. Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry. 1997;54:737–742.
   PubMed Web of Science ®Google Scholar
• Swift R, Oslin DW, Alexander M, Forman R. Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. J Stud Alcohol Drugs. 2011;72:1012–1018.
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Wesson DR, Billot L. Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcohol Clin Exp Res. 2004;28:1051–1059.
   PubMed Web of Science ®Google Scholar
• Garbutt JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293:1617–1625.
   PubMed Web of Science ®Google Scholar
• Lee JD, DiRocco D, Truncali A, et al. Extended-release naltrexone for treatment of alcohol dependence in primary care. J Subst Abuse Treat. 2010;39:14–21.
   PubMed Web of Science ®Google Scholar
• Lee JD, Grossman E, Huben L, et al. Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months. J Subst Abuse Treat. 2012;43:458–462.
   PubMed Web of Science ®Google Scholar
• O’Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. J Clin Psychopharmacol. 2007;27:507–512.
   PubMed Web of Science ®Google Scholar
• Palepu A, Milloy MJ, Kerr T, Zhang R, Wood E. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. J Urban Health. 2011;88:545–555.
   PubMed Web of Science ®Google Scholar
• Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97:2238–2245.
   PubMed Web of Science ®Google Scholar
• Copeland LA, Miller AL, Welsh DE, McCarthy JF, Zeber JE, Kilbourne AM. Clinical and demographic factors associated with homelessness and incarceration among VA patients with bipolar disorder. Am J Public Health. 2009;99:871–877.
   PubMed Web of Science ®Google Scholar
• Bryson W, McConnell J, Korthuis PT, McCarty D. Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization. Am J Manag Care. 2011;17(S8):S222–S234.
   PubMedGoogle Scholar
• Baser O, Chalk M, Rawson R, Gastfriend DR. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes and pharmacotherapy persistence. Am J Manag Care. 2011;17(S8):S222–S234.
   Google Scholar
• Friedmann PD, Mello D, Lonergan S, Bourgault C, O’Toole TP. Aversion to injection limits acceptability of extended-release naltrexone among homeless, alcohol dependent patients. Subst Abus. 2013;34:94–96.
   PubMed Web of Science ®Google Scholar
• Zerger S. Substance Abuse Treatment: What Works for Homeless People? A Review of the Literature. Nashville, TN: National Health Care for the Homeless Council; 2002.
   Google Scholar
• Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10:67.
   PubMed Web of Science ®Google Scholar
• Collins SE, Malone DK, Larimer ME. Motivation to change and treatment attendance as predictors of alcohol-use outcomes among project-based housing first residents. Addict Behav. 2012;37:931–939.
   PubMed Web of Science ®Google Scholar
• Jeste DV, Palmer BW, Appelbaum PS, et al. A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry. 2007;64:966–974.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
   Google Scholar
• Sobell LC, Sobell MB. Timeline followback: a technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ, eds. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press; 1992:41–72.
   Google Scholar
• Tsemberis S, McHugo G, Williams V, Hanrahan P, Stefancic A. Measuring homelessness and residential stability: the residential time-line follow-back inventory. J Community Psychol. 2007;35:29–42.
   Web of Science ®Google Scholar
• Leeman RF, Palmer RS, Corbin WR, Romano DM, Meandzija B, O’Malley SS. A pilot study of naltrexone and BASICS for heavy drinking young adults. Addict Behav. 2008;33:1048–1054.
   PubMed Web of Science ®Google Scholar
• Johnson B, Ait-Daoud N, Roache J. The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field. J Stud Alcohol. 2005;15:157–167.
   Google Scholar
• Levine J, Schooler NR. Strategies for analyzing side-effect data from SAFTEE—a workshop held fall 1985 in Rockville, Maryland. Psychopharmacol Bull. 1986;22:343.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Kushner H, Metzger D, Peters R. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199–213.
   PubMed Web of Science ®Google Scholar
• Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res. 1999;23:1289–1295.
   PubMed Web of Science ®Google Scholar
• Miller W, Tonigan J, Longabaugh R. The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse. Test Manual. Project MATCH Monograph Series Volume 4. Rockville, MD: Alcohol Res Health; 1995.
   Google Scholar
• Wurst FM, Skipper GE, Weinmann W. Ethyl glucuronide—the direct ethanol metabolite on the threshold from science to routine use. Addiction. 2003;98(Suppl 2):51–61.
   PubMed Web of Science ®Google Scholar
• Appenzeller BM, Agirman R, Neuberg P, Yegles M, Wennig R. Segmental determination of ethyl glucuronide in hair: a pilot study. Forensic Sci Int. 2007;20:87–92.
   Web of Science ®Google Scholar
• Jones M, Jones J, Lewis D, et al. Correlation of the alcohol biomarker ethyl glucuronide in fingernails and hair to reported alcohol consumed. Alcohol Clin Exp Res. 2011;35(s1):16a.
   Google Scholar
• O’Malley SS, Corbin WR, Leeman RF, Romano D. Manual for Combining Naltrexone With BASICS for the Treatment of Heavy Alcohol Use in Young Adults. New Haven, CT: Yale University School of Medicine; 2006.
   Google Scholar
• Pettinati HM, Weiss RD, Miller WR, Donovan DM, Ernst DB, Rounsaville BJ. Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of a Treatment for Alcohol Dependence. COMBINE Monograph Series, Volume 2. Bethesda, MD: NIAAA; 2004. DHHS publication no. (NIH) 04-5289.
   Google Scholar
• Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. New York: Guilford Press; 2012.
   Google Scholar
• Hwang SW. Mortality among men using homeless shelters in Toronto, Ontario. JAMA. 2000;283:2152–2157.
   PubMed Web of Science ®Google Scholar
• O’Toole TP, Pollini RA, Ford D, Bigelow G. The health encounter as a treatable moment for homeless substance-using adults: the role of homelessness, health seeking behavior, readiness for behavior change and motivation for treatment. Addict Behav. 2008;33:1239–1243.
   PubMed Web of Science ®Google Scholar
• Padgett D, Stanhope V, Henwood BF, Stefancic A. Substance use outcomes among homeless clients with serious mental illness: comparing housing first with treatment first programs. Community Ment Health J. 2011;47:227–232.
   PubMed Web of Science ®Google Scholar
• Kazdin AE. Research Design in Clinical Psychology. 3rd ed. Needham Heights, MA: Allyn & Bacon; 2003.
   Google Scholar
• Hackshaw A. Small studies: strengths and limitations. Eur Respir J. 2008;32:1141–1143.
   PubMed Web of Science ®Google Scholar